212 related articles for article (PubMed ID: 14711522)
41. Recombinant production of biologically active giant grouper (Epinephelus lanceolatus) growth hormone from inclusion bodies of Escherichia coli by fed-batch culture.
Chung WJ; Huang CL; Gong HY; Ou TY; Hsu JL; Hu SY
Protein Expr Purif; 2015 Jun; 110():79-88. PubMed ID: 25703054
[TBL] [Abstract][Full Text] [Related]
42. Purification and Refolding to Amyloid Fibrils of (His)6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli.
Li Q; Richard CA; Moudjou M; Vidic J
J Vis Exp; 2015 Dec; (106):e53432. PubMed ID: 26709825
[TBL] [Abstract][Full Text] [Related]
43. High-throughput automated refolding screening of inclusion bodies.
Vincentelli R; Canaan S; Campanacci V; Valencia C; Maurin D; Frassinetti F; Scappucini-Calvo L; Bourne Y; Cambillau C; Bignon C
Protein Sci; 2004 Oct; 13(10):2782-92. PubMed ID: 15388864
[TBL] [Abstract][Full Text] [Related]
44. [Expression, renaturation and activity of BAC5-scFv expressed as inclusion body in E.coli].
Tang CH; Xiao XB; Wu T; Liang CS; Liu CZ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):67-70. PubMed ID: 16388749
[TBL] [Abstract][Full Text] [Related]
45. Refolding and one-step purification of recombinant human ARA70 over-expressed in Escherichia coli.
Singh VK; Jia Z
Protein Expr Purif; 2005 Feb; 39(2):283-7. PubMed ID: 15642480
[TBL] [Abstract][Full Text] [Related]
46. Chemically and conformationally authentic active domain of human tissue inhibitor of metalloproteinases-2 refolded from bacterial inclusion bodies.
Williamson RA; Natalia D; Gee CK; Murphy G; Carr MD; Freedman RB
Eur J Biochem; 1996 Oct; 241(2):476-83. PubMed ID: 8917445
[TBL] [Abstract][Full Text] [Related]
47. Expression, purification, and refolding of active recombinant human E-selectin lectin and EGF domains in Escherichia coli.
Kawano S; Iyaguchi D; Okada C; Sasaki Y; Toyota E
Protein J; 2013 Jun; 32(5):386-91. PubMed ID: 23716035
[TBL] [Abstract][Full Text] [Related]
48. Production and purification of refolded recombinant human IL-7 from inclusion bodies.
Ouellette T; Destrau S; Ouellette T; Zhu J; Roach JM; Coffman JD; Hecht T; Lynch JE; Giardina SL
Protein Expr Purif; 2003 Aug; 30(2):156-66. PubMed ID: 12880763
[TBL] [Abstract][Full Text] [Related]
49. Refolding and purification of cGMP-grade recombinant human neurturin from Escherichia coli inclusion bodies.
Xi G; Esfandiary R; Sacramento CB; Jouihan H; Sharma A; Roth R; Linke T
Protein Expr Purif; 2020 Apr; 168():105552. PubMed ID: 31866372
[TBL] [Abstract][Full Text] [Related]
50. Direct refolding of inclusion bodies using reversed micelles.
Sakono M; Kawashima YM; Ichinose H; Maruyama T; Kamiya N; Goto M
Biotechnol Prog; 2004; 20(6):1783-7. PubMed ID: 15575712
[TBL] [Abstract][Full Text] [Related]
51. Solubilization of inclusion body proteins using n-propanol and its refolding into bioactive form.
Singh SM; Sharma A; Upadhyay AK; Singh A; Garg LC; Panda AK
Protein Expr Purif; 2012 Jan; 81(1):75-82. PubMed ID: 21964443
[TBL] [Abstract][Full Text] [Related]
52. Characterization of recombinant pectate lyase refolded from inclusion bodies generated in E. coli BL21(DE3).
Kumar S; Jain KK; Singh A; Panda AK; Kuhad RC
Protein Expr Purif; 2015 Jun; 110():43-51. PubMed ID: 25497420
[TBL] [Abstract][Full Text] [Related]
53. [On-column refolding and purification of human EGF receptor L2 domain inclusion body overexpressed in Escherichia coli].
Xu LH; Hong A; He XH
Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):597-603. PubMed ID: 16176099
[TBL] [Abstract][Full Text] [Related]
54. On-column refolding of recombinant human interleukin-4 from inclusion bodies.
Razeghifard MR
Protein Expr Purif; 2004 Sep; 37(1):180-6. PubMed ID: 15294296
[TBL] [Abstract][Full Text] [Related]
55. Expression of fibronectin-binding protein of L. acidophilus NCFM and in vitro refolding to adhesion capable native-like protein from inclusion bodies.
Bisht S; Singh KS; Choudhary R; Kumar S; Grover S; Mohanty AK; Pande V; Kaushik JK
Protein Expr Purif; 2018 May; 145():7-13. PubMed ID: 29229289
[TBL] [Abstract][Full Text] [Related]
56. Refolding and structural characterization of the human p53 tumor suppressor protein.
Bell S; Hansen S; Buchner J
Biophys Chem; 2002 May; 96(2-3):243-57. PubMed ID: 12034444
[TBL] [Abstract][Full Text] [Related]
57. Purification and refolding of recombinant human interferon-gamma in urea-ammonium chloride solution.
Petrov S; Nacheva G; Ivanov I
Protein Expr Purif; 2010 Sep; 73(1):70-3. PubMed ID: 20363329
[TBL] [Abstract][Full Text] [Related]
58. Highly efficient production of soluble proteins from insoluble inclusion bodies by a two-step-denaturing and refolding method.
Yang Z; Zhang L; Zhang Y; Zhang T; Feng Y; Lu X; Lan W; Wang J; Wu H; Cao C; Wang X
PLoS One; 2011; 6(7):e22981. PubMed ID: 21829569
[TBL] [Abstract][Full Text] [Related]
59. Penicillin-binding protein 2a of Streptococcus pneumoniae: expression in Escherichia coli and purification and refolding of inclusion bodies into a soluble and enzymatically active enzyme.
Zhao G; Meier TI; Hoskins J; Jaskunas SR
Protein Expr Purif; 1999 Jul; 16(2):331-9. PubMed ID: 10419829
[TBL] [Abstract][Full Text] [Related]
60. Expression, purification and characterization of refolded rBm-33 (pepsin inhibitor homolog) from Brugia malayi: a human Lymphatic Filarial parasite.
Krishna NR; Krushna NS; Narayanan RB; Rajan SS; Gunasekaran K
Protein Expr Purif; 2011 Oct; 79(2):245-50. PubMed ID: 21745575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
